The Socioeconomic Evaluation of Medicines: A New Dimension
In moving from traditional endpoints to innovative outcomes in determining the benefits of medicines, five aspects should be considered, namely, the key issues to be addressed, the need for such a change direction, the benefits of the socioeconomic approach, the opportunities available in estimating benefits, and the principles to be considered and implemented.
KeywordsHealth Care Expenditure Obstructive Lung Disease Life Assessment Socioeconomic Benefit Innovative Outcome
Unable to display preview. Download preview PDF.
- 2.Buxton MJ, Drummond MR (1990) Quality of life measurement in the development of medicines. Pharmaceut J 3 Mar:260–262Google Scholar
- 3.Read JL (1988) From medical to socioeconomic evaluation of drug therapy. In: van Eimeren W, Horisberger B (eds) Socioeconomic evaluation of drug therapy. Springer, Berlin Heidelberg New York Tokyo, pp 72–81Google Scholar
- 4.Spilker B (1990) Quality of life assessment in clinical trials. Raven, New YorkGoogle Scholar